The Eurasian Development Bank (EDB), a leading multilateral development bank fostering economic growth in the Eurasian region, has redeemed its five-year Eurobond issue (ISIN XS2315951041). The total amount paid to investors at redemption was 286 million euro, comprising the final coupon payment and repayment of the outstanding principal. The Eurobonds were originally issued under the Bank's EMTN Programme with a nominal issue size of 300 million euro. The bonds were listed on Euronext Dubl...

Vonage, part of Ericsson (NASDAQ: ERIC), today announced the launch of its native integration with ServiceNow Voice, built on the ServiceNow AI Platform, embedding enterprise-grade voice and real-time AI capabilities directly into ServiceNow Customer Service Management (CSM) and IT Service Management (ITSM) workflows for Vonage Contact Center (VCC) customers. Vonage provides a unified service environment for enterprise customer service and IT support teams, enabling agents to deliver exceptiona...

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XI, L.P. has successfully completed the sale of SPX FLOW, Inc. (“SPX FLOW”), a leading provider of highly engineered equipment and process technologies for attractive end markets including industrial, health and nutrition, to ITT Inc. (NYSE: ITT) for $4.775 billion in cash and shares of ITT common stock. SPX FLOW focuses on process technologies delivering mixing, blending, fluid handling, separation, thermal hea...

Smartly announced today an integration with Amazon DSP that enables advertisers to extend their Smartly video campaigns to Amazon's premium CTV inventory, including Prime Video and Fire TV, and third-party publisher inventory. The new integration addresses growing market demand as CTV investment accelerates, with nearly 70% of marketers1 planning to increase streaming budgets over the next year while seeking more personalization, agility, and measurable outcomes from their campaigns. The Smartl...

3650 Capital (“3650”), a nationwide alternative commercial real estate lender, special servicer and solutions provider focused on originating, servicing and asset-managing loans and providing advisory support to global institutions, today announced it has been named PERE Credit’s 2025 Alternative Lender of the Year in the sub-$5 billion real estate AUM category. “We are honored to receive this recognition from PERE Credit which reflects the strength of our company’s unique business model as w...

Today, Safe Software (Safe), the creator of FME, the only All-Data, Any-AI enterprise integration platform with true support for spatial data, announced that Model Context Protocol (MCP) capabilities are coming soon to its FME Platform. This update expands what organizations can do with their existing data and workflows. As organizations move AI from experimentation to production they face growing challenges around context management, interoperability, and security. MCP provides a standardize...

Incode Technologies, Inc., the global leader in identity security and fraud prevention, today announced that iBeta PAD testing confirmed Incode’s face liveness technology achieves Level 3 Presentation Attack Detection (PAD) conformance under ISO/IEC 30107-3. "We are the first company to independently achieve iBeta Level 3 conformance on both iOS and Android – with zero errors and without adding friction to users," said Ricardo Amper, Founder & CEO at Incode. "That combination matters. It ...

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced positive, top-line results from the pivotal Phase 3 ADorable-1 trial evaluating efficacy and safety of lebrikizumab for children and adolescents with moderate-to-severe atopic dermatitis aged 6 months to <18 years. Lebrikizumab met both co-primary and key secondary endpoints, delivering near-complete skin clearance, reduced disease severity, itch relief and improved quality of life at Wee...

Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in Japan.1,2 The products – designed for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds – are now commercially available in the market.1,2 Restylane Defyne and Refyne leverage the unique balance of softness, flexibility, and support delivered ...